Yazar "Arslan, Ulku Yalcintas" seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.(Lippincott Williams & Wilkins, 2014) Uncu, Dogan; Bayoglu, Ibrahim Vedat; Arslan, Ulku Yalcintas; Kucukoner, Mehmet; Artac, Mehmet; Koca, Dogan; Oguz, Arzu[Abstract Not Availabe]Öğe Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.(Lippincott Williams & Wilkins, 2014) Uncu, Dogan; Bayoglu, Ibrahim Vedat; Arslan, Ulku Yalcintas; Kucukoner, Mehmet; Artac, Mehmet; Koca, Dogan; Oguz, Arzu[Abstract Not Availabe]Öğe A retrospective evaluation of locally advanced thymoma and thymic carcinoma: Factors influencing the prognosis after local treatment modalities.(Lippincott Williams & Wilkins, 2013) Arslan, Ulku Yalcintas; Geredeli, Caglayan; Ozdemir, Nuriye; Ciltas, Aydin; Sonmez, Ozlem; Kucukoner, Mehmet; Karaca, Halit[Abstract Not Availabe]Öğe The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.(Amer Soc Clinical Oncology, 2018) Akbulut, Hakan; Ocal, Muge; Sonugur, Fatma Gizem; Abgarmi, Samira Abdi; Babahan, Cansu; Akay, Busra; Arslan, Ulku Yalcintas[Abstract Not Availabe]Öğe The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.(Amer Soc Clinical Oncology, 2018) Akbulut, Hakan; Ocal, Muge; Sonugur, Fatma Gizem; Abgarmi, Samira Abdi; Babahan, Cansu; Akay, Busra; Arslan, Ulku Yalcintas[Abstract Not Availabe]
